Table 4 Correlation of BSRTC categories with BRAFV600E mutation and final diagnosis.

From: Value of TIRADS, BSRTC and FNA-BRAFV600E mutation analysis in differentiating high-risk thyroid nodules

BSRTC categories

n (%)

Surgery (%)

BRAFV600E

Malignant

Malignant Rate

mutation (%)

(95% CI)

I (Nondiagnostic)

43 (19.5)

20 (46.5)

10 (23.3)

12

27.9 (13.3–43.7)

II (Benign)

38 (17.3)

12 (31.6)

3 (7.9)

3

7.9 (1.7–21.4)

III (AUS/FLUS)

33 (15.0)

21 (63.6)

14 (42.4)

15

45.5 (28.1–63.7)

IV (FN/SFN)

4 (1.8)

4 (100.0)

0 (0.0)

3

75.0 (19.4–99.4)

V (Suspicious for malignancy)

65 (29.5)

65 (100.0)

55 (84.6)

64

98.5 (91.7–100.0)

VI (Malignancy)

37 (16.8)

37 (100.0)

32 (86.5)

37

100.0 (90.5–100.0)

  1. Abbreviations: AUS/FLUS, atypia of undetermined significance or follicular lesion of undetermined significance; FN/SFN, follicular neoplasm or suspicious for a follicular neoplasm; CI, confidence interval.
Back to article page